Friday, August 26, 2011

CASAA Testimony - FDA MRTP Workshop

FDA Workshop - Scientific Evaluation on Modified Risk Tobacco Products CASAA Public Testimony by CASAA Vice President Elaine Keller, CASAA Advisor Bill Godshall of Smokefree Pennsylvania, along with other tobacco harm reduction advocates.

The purpose of the public workshop is to discuss issues pertinent to the scientific evaluation of modified risk tobacco product (MRTP) applications. The workshop will feature 5 moderated panel discussions on the following topics:

  • Assessing the Potential Effects of MRTPs on Individuals and Populations
    • Benefit to Individual Tobacco Users
    • Impact on the Health of the Population as a Whole
  • Comparisons of MRTPs to other Tobacco Products
  • Modified Risk Claims for Reduced Substance Exposure
  • Consumer Perceptions of MRTPs
  • Post-Market Surveillance and Studies of Commercially Marketed MRTPs 

Read Elaine's presentation here:

Watch home video of presentations on Youtube:

Recorded video will be posted here:

Read first-hand accounts on ECF forum here: 

No comments: